Deutsche Bank’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.95M | Buy |
616,919
+46,062
| +8% | +$295K | ﹤0.01% | 1335 |
|
|
2025
Q1 | $2.02M | Hold |
570,857
| – | – | ﹤0.01% | 1724 |
|
|
2024
Q4 | $2.16M | Hold |
570,857
| – | – | ﹤0.01% | 1788 |
|
|
2024
Q3 | $1.85M | Hold |
570,857
| – | – | ﹤0.01% | 1771 |
|
|
2024
Q2 | $1.08M | Sell |
570,857
-185,312
| -25% | -$352K | ﹤0.01% | 1922 |
|
|
2024
Q1 | $2.15M | Sell |
756,169
-96,831
| -11% | -$275K | ﹤0.01% | 1605 |
|
|
2023
Q4 | $12.6M | Buy |
853,000
+828,584
| +3,394% | +$12.2M | 0.01% | 918 |
|
|
2023
Q3 | $447K | Sell |
24,416
-167,195
| -87% | -$3.06M | ﹤0.01% | 2216 |
|
|
2023
Q2 | $4.13M | Buy |
191,611
+160,291
| +512% | +$3.46M | ﹤0.01% | 1307 |
|
|
2023
Q1 | $919K | Buy |
31,320
+9,359
| +43% | +$275K | ﹤0.01% | 2152 |
|
|
2022
Q4 | $811K | Buy |
21,961
+6,977
| +47% | +$258K | ﹤0.01% | 2171 |
|
|
2022
Q3 | $422K | Buy |
14,984
+10,292
| +219% | +$290K | ﹤0.01% | 2459 |
|
|
2022
Q2 | $90K | Sell |
4,692
-657
| -12% | -$12.6K | ﹤0.01% | 3535 |
|
|
2022
Q1 | $69K | Buy |
+5,349
| New | +$69K | ﹤0.01% | 3659 |
|